All Stories

  1. Polymer-lipid hybrid nanoparticles of exemestane for improved oral bioavailability and anti-tumor efficacy: An extensive preclinical investigation
  2. Harnessing natural polysaccharides-based nanoparticles for oral delivery of phytochemicals: Knocking down the barriers
  3. Nanomaterials in Cancer Immunotherapy: A Spotlight on Breast Cancer
  4. Promising prospects of lipid-based topical nanocarriers for the treatment of psoriasis
  5. Nanogels as Potential Delivery Vehicles in Improving the Therapeutic Efficacy of Phytopharmaceuticals
  6. Development of cannabidiol nanoemulsion for direct nose to brain delivery: statistical optimization, in vitro and in vivo evaluation
  7. Harnessing Lipid Polymer Hybrid Nanoparticles for Enhanced Oral Bioavailability of Thymoquinone: In Vitro and In Vivo Assessments
  8. Current Insight into the Therapeutic Potential of Phytocompounds and their Nanoparticle-Based Systems for Effective Management of Lung Cancer
  9. Formulation, optimization and evaluation of vitamin E TPGS emulsified dorzolamide solid lipid nanoparticles
  10. Receptor-Mediated Targeted Delivery of Surface-ModifiedNanomedicine in Breast Cancer: Recent Update and Challenges
  11. Recent Advancement in Chitosan-Based Nanoparticles for Improved Oral Bioavailability and Bioactivity of Phytochemicals: Challenges and Perspectives
  12. Box-Behnken Design Assisted Development and Optimization of RP-HPLC-PDA Technique for Determination of Cannabidiol in the Bulk and Nanoformulation
  13. Advancement in design of nanostructured lipid carriers for cancer targeting and theranostic application
  14. Physical Characterization Technique for Nanoemulsions
  15. Thymoquinone loaded chitosan - Solid lipid nanoparticles: Formulation optimization to oral bioavailability study
  16. Exemestane encapsulated polymer-lipid hybrid nanoparticles for improved efficacy against breast cancer: optimization, in vitro characterization and cell culture studies
  17. Fundamental Aspects of Targeted Drug Delivery
  18. Chitosan Coated Luteolin Nanostructured Lipid Carriers: Optimization, In Vitro-Ex Vivo Assessments and Cytotoxicity Study in Breast Cancer Cells
  19. Progress in nanomedicine-based drug delivery in designing of chitosan nanoparticles for cancer therapy
  20. Thymoquinone-entrapped chitosan-modified nanoparticles: formulation optimization to preclinical bioavailability assessments
  21. Obstructions in Nanoparticles Conveyance, Nano-Drug Retention, and EPR Effect in Cancer Therapies
  22. Receptor-Based Combinatorial Nanomedicines
  23. Nanostructured Lipid Carriers (NLCs): Nose-to-Brain Delivery and Theranostic Application
  24. Progress of Cancer Nanotechnology as Diagnostics, Therapeutics, and Theranostics Nanomedicine: Preclinical Promise and Translational Challenges
  25. Effect of Chitosan Coating on PLGA Nanoparticles for Oral Delivery of Thymoquinone: In Vitro, Ex Vivo, and Cancer Cell Line Assessments
  26. Molecular Targets and Nanoparticulate Systems Designed for the Improved Therapeutic Intervention in Glioblastoma Multiforme
  27. Optimization to development of chitosan decorated polycaprolactone nanoparticles for improved ocular delivery of dorzolamide: In vitro, ex vivo and toxicity assessments
  28. Advancement in Nanotheranostics for Effective Skin Cancer Therapy: State of the Art
  29. Polymer-Lipid Hybrid Systems: Scope of Intravenous-To-Oral Switch in Cancer Chemotherapy
  30. Bilosomes nanocarriers for improved oral bioavailability of acyclovir: A complete characterization through in vitro, ex-vivo and in vivo assessment
  31. Recent Advances in the Development of Nanoparticles for Oral Delivery
  32. Therapeutic Nanoemulsion: Concept to Delivery
  33. Nanomedicines in Diagnosis and Treatment of Cancer: An Update
  34. Polymer-Lipid Hybrid Nanoparticles: A Next-Generation Nanocarrier for Targeted Treatment of Solid Tumors
  35. Polymeric Nanomedicines in Treatment of Breast Cancer: Review of Contemporary Research
  36. Cilnidipine loaded transfersomes for transdermal application: Formulation optimization, in-vitro and in-vivo study
  37. PI3K/AKT/mTOR pathway inhibitors in triple-negative breast cancer: a review on drug discovery and future challenges
  38. Quality by design driven development and optimization of teriflunomide loaded nanoliposomes for treatment of rheumatoid arthritis: An in vitro and in vivo assessments
  39. 3D Printing Technology in Design of Pharmaceutical Products
  40. Paclitaxel-loaded Nanolipidic Carriers with Improved Oral Bioavailability and Anticancer Activity against Human Liver Carcinoma
  41. QbD Considerations for Topical and Transdermal Product Development
  42. Nano-Based Therapy for Treatment of Skin Cancer
  43. Phytochemical based nanomedicines against cancer: current status and future prospects
  44. Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and in vivo assessments
  45. Nanotechnology Based Theranostic Approaches in Alzheimer's Disease Management: Current Status and Future Perspective
  46. Nanocarriers in advanced drug targeting: setting novel paradigm in cancer therapeutics
  47. Bile Salt Stabilized Vesicles (Bilosomes): A Novel Nano-Pharmaceutical Design for Oral Delivery of Proteins and Peptides
  48. Improved pharmacokinetics and antihyperlipidemic efficacy of rosuvastatin-loaded nanostructured lipid carriers
  49. Nanostructured Lipid Carriers: A Novel Platform for Chemotherapeutics
  50. Nanotechnology-based inhalation treatments for lung cancer: state of the art